Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1996Journal of Clinical Oncology

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

View Full Paper
Ask AI
Bookmark
Share

Authors

DJDouglas H. JohnsonUniversity of MinnesotaDPD PaulKHKenneth R. HandeVanderbilt University Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Johnson et al. (1996) studied this question.

synapsesocial.com/papers/6a83f8a4f72f0ca72062d306https://doi.org/10.1200/jco.1996.14.7.2054
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Confidence Intervals for Reporting Results of Clinical Trials1986 · 421 citations
  2. 2Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer.1993 · 129 citations
  3. 3Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.1992 · 384 citations
  4. 4Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results1993 · 339 citations
  5. 5Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.1994 · 136 citations